Total Holdings
71
Portfolio diversification across 71 positions
FMED
(NASDAQ)Fidelity Disruptive Medicine ETF
$25.84-- (--)
Loading... - Market loading
FMED ETF Holdings: Fidelity Disruptive Medicine ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$62.05M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Fidelity
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Exact Sciences Corporation | Stock | 5.22% |
| 2 |  | argenx NV ADR | Stock | 4.63% |
| 3 |  | Boston Scientific Corporation | Stock | 4.54% |
| 4 |  | Danaher Corporation | Stock | 4.43% |
| 5 |  | Alnylam Pharmaceuticals, Inc | Stock | 4.41% |
| 6 | E EBR:UCB | UCB SA | Stock | 4.29% |
| 7 |  | Cogent Biosciences, Inc. | Stock | 3.63% |
| 8 |  | Insulet Corporation | Stock | 3.15% |
| 9 |  | Veeva Systems Inc. | Stock | 3.13% |
| 10 |  | Intuitive Surgical, Inc | Stock | 2.96% |
| 11 |  | Penumbra, Inc | Stock | 2.75% |
| 12 |  | Waystar Holding Corp. Common Stock | Stock | 2.60% |
| 13 |  | LifeStance Health Group, Inc. | Stock | 2.35% |
| 14 |  | Edwards Lifesciences Corporation | Stock | 2.31% |
| 15 |  | Moderna, Inc. | Stock | 2.06% |
| 16 |  | Vaxcyte, Inc. | Stock | 2.04% |
| 17 |  | Masimo Corporation | Stock | 2.01% |
| 18 |  | Insmed Incorporated | Stock | 2.00% |
| 19 |  | Legend Biotech Corporation | Stock | 1.96% |
| 20 | E EPA:DIM | Sartorius Stedim Biotech S.A. | Stock | 1.93% |
| 21 |  | Thermo Fisher Scientific Inc. | Stock | 1.89% |
| 22 |  | Eli Lilly and Company | Stock | 1.87% |
| 23 |  | Stryker Corporation | Stock | 1.78% |
| 24 |  | Disc Medicine Inc. | Stock | 1.65% |
| 25 |  | Privia Health Group, Inc. | Stock | 1.63% |
| 26 |  | Natera, Inc | Stock | 1.49% |
| 27 |  | UnitedHealth Group Incorporated | Stock | 1.46% |
| 28 |  | Ascendis Pharma AS | Stock | 1.34% |
| 29 |  | Cytokinetics, Incorporated | Stock | 1.33% |
| 30 |  | ResMed Inc | Stock | 1.32% |
| 31 |  | Crinetics Pharmaceuticals Inc | Stock | 1.32% |
| 32 | S SWX:LONN | Lonza Group AG | Stock | 1.29% |
| 33 | M MRUS | Merus BV | Stock | 1.27% |
| 34 |  | Cidara Therapeutics Inc | Stock | 1.19% |
| 35 |  | DexCom, Inc | Stock | 1.18% |
| 36 |  | Stoke Therapeutics, Inc | Stock | 1.11% |
| 37 |  | Veracyte, Inc | Stock | 1.07% |
| 38 |  | Xenon Pharmaceuticals Inc | Stock | 1.04% |
| 39 |  | Doximity, Inc. | Stock | 0.99% |
| 40 |  | Inspire Medical Systems, Inc | Stock | 0.98% |
| 41 |  | Repligen Corporation | Stock | 0.97% |
| 42 |  | Janux Therapeutics Inc | Stock | 0.85% |
| 43 |  | iRhythm Technologies, Inc | Stock | 0.85% |
| 44 |  | Phreesia Inc | Stock | 0.83% |
| 45 |  | Bruker Corporation | Stock | 0.82% |
| 46 |  | Kymera Therapeutics, Inc | Stock | 0.80% |
| 47 |  | Zai Lab Limited | Stock | 0.78% |
| 48 |  | 10x Genomics, Inc | Stock | 0.77% |
| 49 |  | Kestra Medical Technologies, Ltd. Common Stock | Stock | 0.76% |
| 50 |  | CytomX Therapeutics, Inc | Stock | 0.70% |